Literature DB >> 3951434

Effect of the polar head structure of polyene macrolide antifungal antibiotics on the mode of permeabilization of ergosterol- and cholesterol-containing lipidic vesicles studied by 31P-NMR.

B Cybulska, M Herve, E Borowski, C M Gary-Bobo.   

Abstract

Natural polyene macrolide antibiotics and their N-acyl and methyl ester derivatives, which differ mainly in their electric net charge, were compared for their ability to increase the ionic permeability of large unilamella vesicles, using the proton-cation exchange method and 31P-NMR spectroscopy. The zwitterionic (amphotericin B, vacidin A) and negatively charged (N-N'-diacetyl vacidin) compounds induced permeability according to an all-or-none process on both cholesterol- and ergosterol-containing membranes. The same mechanism of permeability induction is obtained only on ergosterol-containing vesicles for positively charged antibiotics (perimycin A, vacidin A methyl ester, amphotericin B methyl ester). A different type of action is observed for the latter group of ionophores in cholesterol-containing vesicles. In this case, a progressive proton efflux occurs in which all of the vesicle population is involved. This qualitative difference in the kinetics of ionic fluxes induced by antibiotics without a free carboxyl group in cholesterol-containing as compared to ergosterol-containing membranes was ascribed to differences in polyene-sterol interactions as well as in the life time of the ionic path formed. This difference may provide a basis for the improvement of selective toxicity of this group of antifungal agents by rational modifications.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3951434

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  Rapid and pervasive occupation of fallen mangrove leaves by a marine zoosporic fungus.

Authors:  S Y Newell; J D Miller; J W Fell
Journal:  Appl Environ Microbiol       Date:  1987-10       Impact factor: 4.792

Review 2.  Amphotericin B: delivery systems.

Authors:  J Brajtburg; W G Powderly; G S Kobayashi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

Review 3.  Amphotericin B: current understanding of mechanisms of action.

Authors:  J Brajtburg; W G Powderly; G S Kobayashi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

4.  Conformational properties of amphotericin B amide derivatives--impact on selective toxicity.

Authors:  H Resat; F A Sungur; M Baginski; E Borowski; V Aviyente
Journal:  J Comput Aided Mol Des       Date:  2000-10       Impact factor: 3.686

5.  Cholesterol and ergosterol influence nystatin surface aggregation: relation to pore formation.

Authors:  Ana Coutinho; Liana Silva; Alexander Fedorov; Manuel Prieto
Journal:  Biophys J       Date:  2004-08-17       Impact factor: 4.033

6.  Formation of two different types of ion channels by amphotericin B in human erythrocyte membranes.

Authors:  Eneida A Romero; Elizabeth Valdivieso; B Eleazar Cohen
Journal:  J Membr Biol       Date:  2009-07-23       Impact factor: 1.843

7.  Cation conductance and efflux induced by polyene antibiotics in the membrane of skeletal muscle fiber.

Authors:  N Shvinka; G Caffier
Journal:  Biophys J       Date:  1994-07       Impact factor: 4.033

8.  The effect of sterols on amphotericin B self-aggregation in a lipid bilayer as revealed by free energy simulations.

Authors:  Anna Neumann; Maciej Baginski; Szymon Winczewski; Jacek Czub
Journal:  Biophys J       Date:  2013-04-02       Impact factor: 4.033

Review 9.  Optimizing efficacy of Amphotericin B through nanomodification.

Authors:  Gillian Barratt; Stéphane Bretagne
Journal:  Int J Nanomedicine       Date:  2007

Review 10.  Eleutherine bulbosa (Mill.) Urb. Bulb: Review of the Pharmacological Activities and Its Prospects for Application.

Authors:  Ammar Akram Kamarudin; Nor Hafiza Sayuti; Norazalina Saad; Nor Asma Ab Razak; Norhaizan Mohd Esa
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.